Advertisement

Table of contents

  1. Front Matter
    Pages 1-38
  2. Neurotoxins

    1. Front Matter
      Pages 1-1
    2. Richard M. Kostrzewa
      Pages 3-67
    3. Jing Chen, Richard M. Kostrzewa, Xingshun Xu
      Pages 69-93
    4. Pablo Caviedes, Raúl Caviedes, Juan Segura-Aguilar
      Pages 95-108
    5. G. Jean Harry, Christopher A. McPherson
      Pages 109-132
    6. Juan Segura-Aguilar, Ulises Ahumada-Castro, Irmgard Paris
      Pages 199-218
    7. Aleksandra Bortel
      Pages 219-236
    8. Livia Pasquali, Elena Caldarazzo-Ienco, Francesco Fornai
      Pages 237-275
    9. Teresa Cunha-Oliveira, A. Cristina Rego, Catarina R. Oliveira
      Pages 277-297
    10. Justyna Paterak, Roman Stefański
      Pages 299-325
    11. Jason B. Ochroch, Amanda J. Bressler, Hongyan Yang, Dennis L. Murphy, Stefanie C. Altieri, Anne M. Andrews
      Pages 327-346
    12. Gabrielle N. Turski, Chrysanthy Ikonomidou
      Pages 365-397
    13. Anabel Pérez-Gómez, R. Andrew Tasker
      Pages 399-419
    14. Ewa M. Urbańska, Iwona Chmiel-Perzyńska, Adam Perzyński, Marek Derkacz, Björn Owe-Larsson
      Pages 421-453
    15. Ewa Niedzielska, Bartłomiej Rospond, Lucyna Pomierny-Chamioło, Anna Sadakierska-Chudy, Małgorzata Filip
      Pages 455-512
    16. Bal Ram Singh, Raj Kumar, Shuowei Cai
      Pages 513-551
    17. Raja Mehanna, Joseph Jankovic
      Pages 553-590
    18. Laura Petrosini, P. De Bartolo, D. Cutuli
      Pages 591-609
    19. Ashutosh Kumar, Rakesh Kumar Majhi, Manoj Yadav, Arpad Szallasi, Chandan Goswami
      Pages 611-636
  3. Dopamine Chemistry and Parkinson Disease

    1. Front Matter
      Pages 637-637
    2. Maria F. Galindo, Sara Saez-Atienzar, Maria E. Solesio, Joaquín Jordán
      Pages 639-651
    3. Irmgard Paris, Ulises Ahumada-Castro, Juan Segura-Aguilar
      Pages 653-690
    4. Christine Lund Kragh, Marina Romero-Ramos, Glenda Halliday, Poul Henning Jensen
      Pages 691-726
    5. Miquel Vila, Marta Martínez-Vicente
      Pages 727-751
    6. Rui Daniel Prediger, Mariza Bortolanza, Ana Carolina de Castro Issy, Bruno Lopes dos Santos, Elaine Del Bel, Rita Raisman-Vozari
      Pages 753-788
    7. Marco T. Núñez, Pamela Urrutia, Natalia Mena, Pabla Aguirre
      Pages 789-818
    8. Rosa A. González-Polo, José M. Bravo-San Pedro, Rubén Gómez-Sánchez, Elisa Pizarro-Estrella, Mireia Niso-Santano, José M. Fuentes
      Pages 819-842
    9. Daiana Silva Ávila, Robson Luiz Puntel, Vanderlei Folmer, João Batista Teixeira Rocha, Ana Paula Marreilha dos Santos, Michael Aschner
      Pages 843-864
    10. Juan Segura-Aguilar, Irmgard Paris
      Pages 865-883
    11. F. Ros-Bernal, J. E. Yuste, E. Tarragón, V. Ortiz, A. Gómez, C. M. Ros et al.
      Pages 885-912
    12. Giorgia Greco
      Pages 913-932
    13. H. Nakayama, T. Ito, Y. Shibui, T. Sai, K. Uchida, X. J. He
      Pages 933-951
    14. Jason R. Cannon, J. Timothy Greenamyre
      Pages 995-1012
  4. Glutamate Receptor Agonists and Antagonists

    1. Front Matter
      Pages 1013-1013
    2. Juan C. Piña-Crespo, Sara Sanz-Blasco, Stuart A. Lipton
      Pages 1015-1038
    3. Lotten Ragnarsson, Peter R. Dodd, Matthew R. Hynd
      Pages 1039-1070
    4. Nady Braidy, Anne Poljak, Tharusha Jayasena, Gilles J. Guillemin, Perminder Sachdev
      Pages 1071-1092
    5. Aven Lee, Shannon Beasley, David V. Pow
      Pages 1093-1113
    6. M. Kaul
      Pages 1115-1153
    7. Andrzej Stepulak, Radosław Rola, Krzysztof Polberg
      Pages 1155-1172
    8. Nady Braidy, Anne Poljak, Tharusha Jayasena, Perminder Sachdev
      Pages 1173-1190
    9. Stjepana Kovac, Matthew C. Walker
      Pages 1191-1208
    10. Kim A. Staats, Ludo VanDenBosch
      Pages 1209-1222
    11. Anna E. King, James C. Vickers
      Pages 1223-1245
    12. Belinda Cruse, Bruce J. Brew
      Pages 1247-1265

About this book

Introduction

The Handbook of Neurotoxicity is a reference source for identifying, characterizing, instructing on use, and describing outcomes of neurotoxin treatments – to understand mechanisms associated with toxin use; to project outcomes of neurotoxin treatments; to gauge neurotoxins as predictors of events leading to neurodegenerative disorders and as aids to rational use of neurotoxins to model disease entities. Neuroprotection is approached in different manners including those 1) afforded by therapeutic agents – clinical and preclinical; or 2) by non-drug means, such as exercise. The amorphous term ‘neurotoxin’ is discussed in terms of the possible eventuality of a neuroprotectant producing an outcome of excess neuronal survival and a behavioral spectrum that might produce a dysfunction – akin to a neurotoxin’s effect. The Handbook of Neurotoxicity is thus an instructive and valuable guide towards understanding the role of neurotoxins/neurotoxicity in the expansive field of Neuroscience, and is an indispensable tool for laboratory investigators, neuroscientists, and clinical researchers.

Editors and affiliations

  • Richard M. Kostrzewa
    • 1
  1. 1.Department of Biomedical SciencesEast Tennessee State UniversityJohnson CityUSA

Bibliographic information

Industry Sectors
Biomedicine
Pharma
Biotechnology
Consumer Packaged Goods